Contribution of SA and Coma to The Total Ocular HOA Before and After FS-LASIK Using An Aspheric Ablation Profile
NCT ID: NCT04966806
Last Updated: 2021-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
17 participants
INTERVENTIONAL
2021-07-10
2021-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There is a continuous upgrade and development in LVC surgeries correlated with the evolution of new machines and enhancement of the ablation profiles. One of the main undesirable effects of corneal refractive surgeries using conventional ablation profiles is the increase in HOAs which is associated with haloes, glare, ghost images, starburst patterns and monocular diplopia, especially in low lighting conditions and during night driving.
Over the years many ablation profiles have been developed such as wavefront-guided, wavefront optimized, topography guided, Q- Value based and aspheric ablation profiles. These profiles aim to abolish LOAs and to prevent induction or increase of pre-existing HOAs aiming to improve the quality of vision experienced post-operative.
In spite of the vast body of research in this area, there remains a gap in the literature investigating higher-order aberrations' components in-depth. Therefore, this study aims to investigate the contribution of spherical aberration and coma to the total higher order aberration before and after femtosecond assisted laser in situ keratomileusis using an aspheric ablation profile.
This current study is a Descriptive analytical study that was conducted on 34 eyes of 17 patients who underwent corneal refractive surgery.
The results were analyzed to compare the effect of FS-LASIK surgery on corneal coma and SA, and the contribution of each of them on total ocular HOAs preoperative and post-operative.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Q Value Customized Versus Wavefront Optimized Ablation in Femtosecond Laser-Assisted LASIK
NCT04738903
Corneal High Order Aberrations After Stream Light and Mechanical Photorefractive Keratectomy
NCT06110286
Comparison Between FS- LASIK and FS-SMILE for Correction of Myopia and Myopic Astigmatism
NCT02962544
Assessment of the Preoperative Risk Factors for the Development of Post-LASIK Ectasia
NCT06806306
Analysis of I-Trace High Order Aberrations Induced by Wavefront Optimized Ablation Profiles
NCT04452448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Percentage of Coma and SA to Total ocular HOA
LASIK refractive surgery
laser vision correction for myopic eyes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LASIK refractive surgery
laser vision correction for myopic eyes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Myopes from -1.50 D to -8.00 D
3. Astigmatism less than -4.00 D
4. Normal Corneal Tomography with a Belin Ambrosio big D value of less than 1.6
Exclusion Criteria
2. Corneal thickness less than 500 microns
3. Expected Post Lasik Residual Stromal bed less than 300 microns
4. All patients with post operative complications as epithelial overgrowth or decentered ablation.
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paula Sameh Youssef
Resident.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kasr Al Ainy
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSYoussef
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.